coaprovel 150/12,5 tablet
sanofi industries south africa (pty) ltd - tablet - see ingredients - each tablet contains hydrochlorothiazide 12,5 mg irbesartan 150,0 mg
coaprovel 150/12,5
aventis pharma (pty) limited - irbesartan , hydrochlorothiazide - tablets - each tablet contains irbesartan 150 mg, hydrochlorothiazide 12,5 mg
coaprovel 150mg/12.5mg tablet
sanofi-aventis (malaysia) sdn. bhd. - irbesartan; hydrochlorothiazide -
coaprovel
sanofi winthrop industrie - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.
coaprovel 150mg12.5mg tablets
sanofi - hydrochlorothiazide; irbesartan - tablet - 12.5mg ; 150mg
coaprovel 300mg25mg tablets
sanofi - hydrochlorothiazide; irbesartan - tablet - 25mg ; 300mg
coaprovel film-coated tablet 15012.5 mg
sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; irbesartan 150.00 mg
coaprovel 150/12,5 mg 28 comprimits cub pelic
coaprovel film-coated tablet 30025mg
sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 25.00mg - hydrochlorothiazide 25.00mg; irbesartan 300.00mg
coaprovel film-coated tablet 30012.5 mg
sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; irbesartan 300.00 mg